Visit COVID-19 resources

[Skip to Content]

Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction – (Eye 30, 1056 (August 2016))

Aug 11
2016

Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction Eye 30, 1056 (August 2016). doi:10.1038/eye.2016.88 Authors: P Kaynak, G O Karabulut, C Ozturker, K Fazil, Y O Arat, I Perente, S Akar, O F Yilmaz & A Demirok

  • 11 August 2016

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study – (Eye 30, 1063 (August 2016))

Aug 11
2016

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study Eye 30, 1063 (August 2016). doi:10.1038/eye.2016.90 Authors: F G Holz, R Tadayoni, S Beatty, A R Berger, M G Cereda, P Hykin, G Staurenghi, K Wittrup-Jensen, J Nilsson, K Kim & S Sivaprasad

  • 11 August 2016

Variability of disease activity in patients treated with ranibizumab for neovascular age-related macular degeneration – (Eye 30, 1072 (August 2016))

Aug 11
2016

Variability of disease activity in patients treated with ranibizumab for neovascular age-related macular degeneration Eye 30, 1072 (August 2016). doi:10.1038/eye.2016.97 Authors: P Enders, P Scholz, P S Muether & S Fauser

  • 11 August 2016

Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy – (Eye 30, 1077 (August 2016))

Aug 11
2016

Aflibercept in persistent neovascular AMD: comparison of different treatment strategies in switching therapy Eye 30, 1077 (August 2016). doi:10.1038/eye.2016.95 Authors: F Ricci, M Parravano, F Regine, M Sciamanna, M Tedeschi, F Missiroli & M Varano

  • 11 August 2016

Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion – (Eye 30, 1084 (August 2016))

Aug 11
2016

Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion Eye 30, 1084 (August 2016). doi:10.1038/eye.2016.96 Authors: J Moon, M Kim & M Sagong

  • 11 August 2016